Solve for X
21 May 2010

Big Pharma s most important drugs are losing patent protection, growth in developed markets has slowed to a crawl, and much of its cash is trapped overseas. Abbott s $3.7 bln purchase of Piramal Healthcare s generics arm offers a partial response.